London, UK; Brentwood, TN, US; 26 February 2007 - Protherics PLC ("Protherics"
or the "Company"), the international biopharmaceutical company focused on
critical care and cancer, announces that the following notification of interest
in the ordinary share capital of the Company was received on 23 February 2007
from AMVESCAP PLC.
